[Home]
[Full version]
New procedure in diagnosing small bowel disorders proves efficient and effective
Apr 11 ,Medicine & Health
Sonoenteroclysis, a new sonographic method in evaluating and diagnosing small bowel disorders is an effective alternative to the usual method of barium enteroclysis, according to a recent study conducted by researchers at the Postgraduate Institute of Medical Education and Research in Chandigarh, India. Sonoenteroclysis is a new way of doing transabdominal ultrasound. Patients are given fluid through the nasojejunal tube in order to alleviate gas in the bowel.
“Various techniques available until now for evaluating the small bowel have been either inadequate or have various disadvantages and limitations,” said Birinder Nagi, MD, lead author of the study. “Radiologic evaluation of the small bowel is usually done by barium examination which cannot evaluate the bowel wall and surrounding structures. With CT enteroclysis, another method, mucosal details cannot be well seen. Both of these techniques are associated with increased exposure to radiation.
PET-CT enteroclysis is a new promising technique, but also requires ionizing radiation. MR enteroclysis is not widely available and there is concern about patients vomiting in the gantry while they are undergoing the examination.
The study consisted of 50 patients with suspected small bowel disorder who underwent sonoenteroclysis followed by barium enteroclysis. The findings of the two were compared. The researchers noted small bowel thickness, luminal diameter, peristalsis and extra intestinal lesions. Of the 50 patients, 10 showed normal small bowel on both sonoenteroclysis and barium enteroclysis. The study also showed that 25 of the remaining 40 patients showed abnormality in the form of: strictures, dilated loops, thickened folds, mass lesions, etc. on both techniques as well. Additional findings on sonoenteroclysis were thickened bowel wall with loss of stratification, ascites, and lymphadenopathy. These were later diagnosed as cases of tuberculosis.
“The results of sonoenteroclysis were comparable to barium enteroclysis and also provided additional information regarding bowel wall and surrounding structures,” said Dr. Nagi. “This examination is simple, non-invasive, without radiation, cheap and can be used as an initial investigation in patients with suspected small bowel diseases,” he said.
Source: American Roentgen Ray Society
Related stories:
Study shows stool DNA testing for colorectal cancer has potential, but challenges remain
The first generation of a stool DNA test to identify early colorectal cancer has limitations, according to a Mayo Clinic-led study published in the Oct. 7, 2008, issue of
Annals of Internal Medicine. Results did not corroborate findings of an earlier multicenter study that showed stool DNA testing was more accurate than fecal blood testing for colorectal cancer detection. *
Form of Crohn's disease traced to disabled gut cells
Scientists report online this week in
Nature that they have linked the health of specialized gut immune cells to a gene associated with Crohn's disease, an often debilitating and increasingly prevalent inflammatory bowel disorder.
Study confirms colonoscopy associated with reduced colorectal cancer incidence
Patients who undergo a complete negative colonoscopy have a reduced incidence of colorectal cancer, confirms a study published in Clinical Gastroenterology and Hepatology. However, in the proximal colon, the incidence reduction of colorectal cancer following complete negative colonoscopy differs in magnitude and timing.
Most adults under 50 unlikely need colorectal screening
Young adults without a family history of bowel disease are unlikely to develop adenomas, the colorectal polyps most likely to lead to cancer, according to new research directed by scientists at the Johns Hopkins Kimmel Cancer Center. The finding supports current cancer screening guidelines recommending adults in general undergo screening colonoscopies starting at age 50.
MS patients have higher spinal fluid levels of suspicious immune molecule
A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease.
Researchers develop new model for cystic fibrosis
In a first, researchers at the University of Iowa and the University of Missouri (MU) have developed a pig model for cystic fibrosis (CF) that appears to closely mimic the disease in human infants. The striking similarities between disease manifestations in the CF piglets and human newborns with CF suggest that this new model will help improve understanding of the disease and may also speed discovery of new treatments. The study is published in the Sept. 26 issue of
Science.
Simple, inexpensive and objective tools for the assessment of mucosal inflammation: fecal markers
UC and CD, the two major forms of IBD are chronic, idiopathic inflammatory conditions of the gut with a typically relapsing and remitting course. A prominent feature in mucosal biopsies from patients with active IBD is infiltration by neutrophil granulocytes. Moreover, the number of eosinophil granulocytes is also increased in IBD. Upon activation, neutrophils release Calprotectin and MPO, two major neutrophil proteins, while eosinophils release the protein, EPX. Previous studies have shown that fecal markers may be used to differentiate IBD from functional gastrointestinal disorders, but the usefulness of these markers in monitoring therapy of patients with active relapse of IBD needs further evaluation.
New options when an old enemy returns
Pancreatic cancer is one of the most challenging malignancies to treat, and recurrence is common, even after initial treatment with surgery and radiation. When the cancer does return, treatment options are often limited to chemotherapy, but researchers at Georgetown's Lombardi Comprehensive Cancer Center are utilizing the precision allowed by CyberKnife® to see if radiosurgery is a viable treatment option in select patients.
[Home]
[Full version]